Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation
- 30 June 2006
- journal article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 66 (1), 133-134
- https://doi.org/10.1136/ard.2006.057745
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 yearsRheumatology, 2005
- Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)Arthritis & Rheumatism, 2005
- International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2003
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984